PH30480A - Carboxamides - Google Patents
CarboxamidesInfo
- Publication number
- PH30480A PH30480A PH48901A PH48901A PH30480A PH 30480 A PH30480 A PH 30480A PH 48901 A PH48901 A PH 48901A PH 48901 A PH48901 A PH 48901A PH 30480 A PH30480 A PH 30480A
- Authority
- PH
- Philippines
- Prior art keywords
- carboxamides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH266793 | 1993-09-07 | ||
CH215094 | 1994-07-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
PH30480A true PH30480A (en) | 1997-05-28 |
Family
ID=25689654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH48901A PH30480A (en) | 1993-09-07 | 1994-09-02 | Carboxamides |
Country Status (15)
Country | Link |
---|---|
US (1) | US5559232A (ru) |
EP (1) | EP0641779A1 (ru) |
JP (1) | JP2614984B2 (ru) |
CN (1) | CN1107839A (ru) |
AU (1) | AU684295B2 (ru) |
CA (1) | CA2130864A1 (ru) |
CZ (1) | CZ213594A3 (ru) |
FI (1) | FI944100A (ru) |
HU (1) | HUT70616A (ru) |
IL (1) | IL110834A (ru) |
NO (1) | NO301976B1 (ru) |
NZ (1) | NZ264357A (ru) |
PH (1) | PH30480A (ru) |
RU (1) | RU2125991C1 (ru) |
TW (1) | TW394760B (ru) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6984627B1 (en) | 1993-06-03 | 2006-01-10 | Astrazeneca Ab | Peptide derivatives |
US5536867A (en) * | 1994-04-27 | 1996-07-16 | Hoffmann-La Roche Inc. | Process for the manufacture of dicarboxamides |
EP0684238A3 (en) * | 1994-04-27 | 1997-01-15 | Hoffmann La Roche | Process for the preparation of dicarboxamides. |
DE4437137A1 (de) * | 1994-10-18 | 1996-04-25 | Hoechst Schering Agrevo Gmbh | Substituierte Cycloalkylamino- und -alkoxy-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel |
GB9424353D0 (en) * | 1994-12-02 | 1995-01-18 | Ici Plc | Surfactants |
SA96170106A (ar) | 1995-07-06 | 2005-12-03 | أسترا أكتيبولاج | مشتقات حامض أميني جديدة |
AR005245A1 (es) * | 1995-12-21 | 1999-04-28 | Astrazeneca Ab | Prodrogas de inhibidores de trombina, una formulación farmaceutica que las comprende, el uso de dichas prodrogas para la manufactura de un medicamento y un procedimiento para su preparacion |
SE9602263D0 (sv) | 1996-06-07 | 1996-06-07 | Astra Ab | New amino acid derivatives |
SE9602646D0 (sv) | 1996-07-04 | 1996-07-04 | Astra Ab | Pharmaceutically-useful compounds |
AU7453498A (en) | 1997-05-30 | 1998-12-30 | Takeda Chemical Industries Ltd. | Sulfonamide derivatives, their production and use |
AR013084A1 (es) | 1997-06-19 | 2000-12-13 | Astrazeneca Ab | Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados |
SE9704543D0 (sv) | 1997-12-05 | 1997-12-05 | Astra Ab | New compounds |
UA59433C2 (ru) * | 1998-01-27 | 2003-09-15 | Авентіс Фармасьютікалс Продактс Інк. | Замещенные оксоазагетероциклические ингибиторы фактора ха |
AU2298899A (en) | 1998-02-05 | 1999-08-23 | Takeda Chemical Industries Ltd. | Sulfonamide derivatives, process for producing the same and utilization thereof |
CA2327507A1 (en) * | 1998-05-05 | 1999-11-11 | Warner-Lambert Company | Succinamide inhibitors of interleukin-1.beta. converting enzyme |
SE9804313D0 (sv) | 1998-12-14 | 1998-12-14 | Astra Ab | New compounds |
CN1170842C (zh) | 1999-01-13 | 2004-10-13 | 阿斯特拉曾尼卡有限公司 | 新的脒基苄基胺衍生物及其作为凝血酶抑制剂的用途 |
US6723722B1 (en) | 1999-06-22 | 2004-04-20 | Takeda Chemical Industries, Ltd. | Acylhydrazine derivatives, their production and use |
SE0001803D0 (sv) | 2000-05-16 | 2000-05-16 | Astrazeneca Ab | New compounds i |
WO2002006234A1 (fr) * | 2000-07-17 | 2002-01-24 | Takeda Chemical Industries, Ltd. | Derives de sulfonate, procede de production et utilisation de ces derives |
US6433186B1 (en) | 2000-08-16 | 2002-08-13 | Astrazeneca Ab | Amidino derivatives and their use as thormbin inhibitors |
AR035216A1 (es) * | 2000-12-01 | 2004-05-05 | Astrazeneca Ab | Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios |
US7129233B2 (en) | 2000-12-01 | 2006-10-31 | Astrazeneca Ab | Mandelic acid derivatives and their use as thrombin inhibitors |
AR034517A1 (es) | 2001-06-21 | 2004-02-25 | Astrazeneca Ab | Formulacion farmaceutica |
SE0201659D0 (sv) | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | Modified release pharmaceutical formulation |
SE0201661D0 (sv) | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | New salts |
AU2003284596A1 (en) * | 2002-11-22 | 2004-06-18 | Takeda Pharmaceutical Company Limited | Imidazole derivative, process for producing the same, and use |
CA2512639C (en) * | 2003-01-16 | 2012-10-30 | Acadia Pharmaceuticals Inc. | Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases |
US20060178370A1 (en) * | 2003-03-18 | 2006-08-10 | Mark Bock | Ketopiperazine derivatives as bradykinin antagonists |
US7781424B2 (en) | 2003-05-27 | 2010-08-24 | Astrazeneca Ab | Modified release pharmaceutical formulation |
JP2007516176A (ja) | 2003-06-20 | 2007-06-21 | アムジエン・インコーポレーテツド | ピペラジン誘導体及び使用方法 |
US7795205B2 (en) * | 2004-04-12 | 2010-09-14 | Canyon Pharmaceuticals, Inc. | Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor |
TWI396686B (zh) | 2004-05-21 | 2013-05-21 | Takeda Pharmaceutical | 環狀醯胺衍生物、以及其製品和用法 |
JP3964417B2 (ja) | 2004-09-27 | 2007-08-22 | 国立大学法人金沢大学 | インドール誘導体を有効成分とするα2受容体遮断剤及び血管拡張剤 |
JP2006298785A (ja) * | 2005-04-18 | 2006-11-02 | Mitsui Chemicals Inc | ジアミン誘導体、その製造方法およびそれらを有効成分とする殺菌剤 |
US7524354B2 (en) * | 2005-07-07 | 2009-04-28 | Research Foundation Of State University Of New York | Controlled synthesis of highly monodispersed gold nanoparticles |
BRPI0709427A2 (pt) * | 2006-03-30 | 2011-07-12 | Palatin Technologies Inc | "construto cìclico, composição farmacêutica e uso de um composto |
ATE539762T1 (de) * | 2006-03-30 | 2012-01-15 | Palatin Technologies Inc | Aminosäureersatz für peptidkonstruktionen |
US8580746B2 (en) | 2006-03-30 | 2013-11-12 | Palatin Technologies, Inc. | Amide linkage cyclic natriuretic peptide constructs |
US7964181B2 (en) * | 2006-03-30 | 2011-06-21 | Palatin Technologies, Inc. | Amino acid surrogates for peptidic constructs |
JP2009532385A (ja) | 2006-03-30 | 2009-09-10 | パラティン・テクノロジーズ・インコーポレーテッド | 線状ナトリウム利尿ペプチド構築物 |
US8114844B2 (en) * | 2006-03-30 | 2012-02-14 | Palatin Technologies, Inc. | Linear and cyclic melanocortin receptor-specific peptidomimetics |
AU2007297013B2 (en) * | 2006-09-13 | 2012-05-31 | Sanofi-Aventis | Isoserine derivatives for use as coagulation factor IXa inhibitors |
KR20090087044A (ko) * | 2006-12-06 | 2009-08-14 | 사노피-아벤티스 | TAFIa 억제제로서의 요소 및 설파미드 유도체 |
TW200827336A (en) | 2006-12-06 | 2008-07-01 | Astrazeneca Ab | New crystalline forms |
ES2361595T3 (es) * | 2007-05-07 | 2011-06-20 | Novartis Ag | Compuestos orgánicos. |
US20090061000A1 (en) * | 2007-08-31 | 2009-03-05 | Astrazeneca Ab | Pharmaceutical formulation use 030 |
CN102056922B (zh) | 2008-06-06 | 2013-11-20 | 赛诺菲-安万特 | 作为tafia抑制剂的大环脲和磺酰胺衍生物 |
EP2321301A4 (en) | 2008-06-23 | 2011-09-28 | Astrazeneca Ab | NOVEL HETEROCYCLIC CARBOXAMIDES AS THROMBIN INHIBITORS |
US8354444B2 (en) | 2008-09-18 | 2013-01-15 | Hoffmann-La Roche Inc. | Substituted pyrrolidine-2-carboxamides |
AU2011327111B2 (en) * | 2010-11-12 | 2015-04-23 | Fujifilm Toyama Chemical Co., Ltd. | Pyrazino[2,3-d]isoxazole Derivative |
WO2014198620A1 (en) | 2013-06-10 | 2014-12-18 | Sanofi | Macrocyclic urea derivatives as inhibitors of tafia, their preparation and their use as pharmaceuticals |
CN104003984B (zh) * | 2014-06-16 | 2016-03-02 | 山东大学 | 噻唑-4-甲酰基哌嗪衍生物及其制备方法与应用 |
CN104016944B (zh) * | 2014-06-16 | 2016-05-18 | 山东大学 | N-(2-(胺甲基)苯基)噻唑-4-甲酰胺衍生物及其制备方法与应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE420919B (sv) * | 1973-08-13 | 1981-11-09 | Mitsubishi Chem Ind | Forfarande for framstellning av n?722-dansyl-l-argininderivat och farmaceutiskt godtagbara syradditionssalter derav |
US4258192A (en) * | 1977-12-16 | 1981-03-24 | Mitsubishi Chemical Industries Limited | N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
US4433152A (en) * | 1981-05-25 | 1984-02-21 | Nippon Chemiphar Co., Ltd. | Amidinopiperidine derivatives |
SE8203887D0 (sv) * | 1982-06-23 | 1982-06-23 | Kabivitrum Ab | Nya trombininhiberande foreningar |
US5053393A (en) * | 1988-07-20 | 1991-10-01 | Monsanto Company | Novel platelet-aggregation inhibitor |
US5037808A (en) * | 1988-07-20 | 1991-08-06 | Monsanto Co. | Indolyl platelet-aggregation inhibitors |
US4879313A (en) * | 1988-07-20 | 1989-11-07 | Mosanto Company | Novel platelet-aggregation inhibitors |
US5084466A (en) * | 1989-01-31 | 1992-01-28 | Hoffmann-La Roche Inc. | Novel carboxamide pyridine compounds which have useful pharmaceutical utility |
TW201303B (ru) * | 1990-07-05 | 1993-03-01 | Hoffmann La Roche | |
ES2065182T3 (es) * | 1991-03-06 | 1995-02-01 | Searle & Co | Derivados de fenilamidinas utiles como inhibidores de la agregacion de plaquetas. |
TW223629B (ru) * | 1992-03-06 | 1994-05-11 | Hoffmann La Roche |
-
1994
- 1994-08-23 TW TW083107736A patent/TW394760B/zh active
- 1994-08-25 CA CA002130864A patent/CA2130864A1/en not_active Abandoned
- 1994-08-30 EP EP94113488A patent/EP0641779A1/de not_active Withdrawn
- 1994-08-31 NZ NZ264357A patent/NZ264357A/en unknown
- 1994-09-01 IL IL11083494A patent/IL110834A/en not_active IP Right Cessation
- 1994-09-02 PH PH48901A patent/PH30480A/en unknown
- 1994-09-02 AU AU72807/94A patent/AU684295B2/en not_active Ceased
- 1994-09-02 US US08/300,821 patent/US5559232A/en not_active Expired - Fee Related
- 1994-09-02 HU HU9402527A patent/HUT70616A/hu unknown
- 1994-09-05 JP JP6234541A patent/JP2614984B2/ja not_active Expired - Lifetime
- 1994-09-05 CZ CZ942135A patent/CZ213594A3/cs unknown
- 1994-09-06 CN CN94109150A patent/CN1107839A/zh active Pending
- 1994-09-06 NO NO943294A patent/NO301976B1/no not_active IP Right Cessation
- 1994-09-07 RU RU94032284A patent/RU2125991C1/ru active
- 1994-09-07 FI FI944100A patent/FI944100A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
FI944100A (fi) | 1995-03-08 |
NO943294L (no) | 1995-03-08 |
NO301976B1 (no) | 1998-01-05 |
IL110834A0 (en) | 1994-11-28 |
RU2125991C1 (ru) | 1999-02-10 |
HU9402527D0 (en) | 1994-10-28 |
CN1107839A (zh) | 1995-09-06 |
FI944100A0 (fi) | 1994-09-07 |
CA2130864A1 (en) | 1995-03-08 |
JP2614984B2 (ja) | 1997-05-28 |
TW394760B (en) | 2000-06-21 |
US5559232A (en) | 1996-09-24 |
AU684295B2 (en) | 1997-12-11 |
NZ264357A (en) | 1996-05-28 |
HUT70616A (en) | 1995-10-30 |
IL110834A (en) | 1998-08-16 |
RU94032284A (ru) | 1996-07-20 |
AU7280794A (en) | 1995-03-23 |
JPH07112970A (ja) | 1995-05-02 |
EP0641779A1 (de) | 1995-03-08 |
NO943294D0 (no) | 1994-09-06 |
CZ213594A3 (en) | 1995-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH30480A (en) | Carboxamides | |
DE69400639D1 (en) | Rehydratationsgetraenk | |
DE69426415D1 (en) | Intrapulmonares hormonabgabesystem | |
DE69421914D1 (en) | Ekg-sensor | |
DE69401926D1 (en) | Hydroxamsäurederivate | |
DE69406448D1 (en) | Luftreinigungsgerät | |
DE69405713D1 (en) | Carbonylierungsverfahren | |
DE69412242D1 (en) | Orthopädisches gussmaterial | |
DE59407177D1 (en) | 2-fluorcycloyhexen-derivate | |
DE69423875D1 (en) | Hydrodealkylierungsverfahren | |
DE69429512D1 (en) | Thermoresistente alpha-1-antitrypsinmütante | |
DE59409705D1 (en) | 3-methoxy-2-phenyl-acrylsäuremethylester | |
DE59408644D1 (en) | Jacquardmaschine | |
DE69408437D1 (en) | Oxychlorierungsverfahren | |
EP0730584A4 (en) | 3-ACYLAMINOBENZODIAZEPINE | |
DE59408733D1 (en) | Metallhalogenidentladungslampe | |
DE59410065D1 (en) | 3-methoxy-2-phenyl-acrylsäuremethylester | |
GB2274048B (en) | Headcollars | |
DE69425743D1 (en) | Faserreaktive anthrachinon-farbstoffe | |
DE69422299D1 (en) | Photographisches reproduktionsgerät | |
DE69412128D1 (en) | Kühlcontainer | |
DE69410761D1 (en) | Polyacetalharzzusammensetzung | |
DE69407946D1 (en) | Oxychlorierungskatalysator | |
GB2291797B (en) | Cases | |
DE69413832D1 (en) | Amidierungskatalysatorkonzentrat |